Cardiovascular Magnetic Resonance for Patients With COVID-19.
Cardiovascular Magnetic Resonance for Patients With COVID-19.
复制标题
DOI：
10.1016/j.jcmg.2021.08.021
复制
发表时间：
2022-04
期刊：
影响因子：
--
通讯作者：
Bluemke DA
中科院分区：
文献类型：
--
作者：
Petersen SE;Friedrich MG;Leiner T;Elias MD;Ferreira VM;Fenski M;Flamm SD;Fogel M;Garg R;Halushka MK;Hays AG;Kawel-Boehm N;Kramer CM;Nagel E;Ntusi NAB;Ostenfeld E;Pennell DJ;Raisi-Estabragh Z;Reeder SB;Rochitte CE;Starekova J;Suchá D;Tao Q;Schulz-Menger J;Bluemke DA
COVID-19与缺血、炎症或心肌炎引起的心肌损伤有关。心血管磁共振（CMR）是心脏功能、结构和组织成分的无创参考标准。CMR对于出现心肌损伤和心功能不全证据的COVID-19患者是一种潜在的有价值的诊断工具。尽管COVID-19相关心肌炎可能并不常见，但已报告高达48%的患者出现COVID-19相关心血管组织病理学结果，这引起了对长期心肌损伤的担忧。迄今为止的研究报告称，26%至60%的COVID-19康复住院患者出现CMR异常，包括功能障碍、心肌组织异常、晚期钆增强或心包异常。在COVID-19后的运动员中，CMR检测到心肌炎样异常。在儿童中，多系统炎症综合征可能在感染后2 - 6周发生;相关的心肌炎和冠状动脉瘤可通过CMR评估。目前，我们对COVID-19相关心血管受累的了解尚不完整，计划进行多项研究，以使用CMR评估COVID-19患者。在这篇综述中，我们总结了COVID-19患者CMR的现有研究，并介绍了正在进行的研究。我们还为有急性症状或从COVID-19中恢复的患者提供CMR的临床使用建议。
COVID-19 is associated with myocardial injury caused by ischemia, inflammation, or myocarditis. Cardiovascular magnetic resonance (CMR) is the noninvasive reference standard for cardiac function, structure, and tissue composition. CMR is a potentially valuable diagnostic tool in patients with COVID-19 presenting with myocardial injury and evidence of cardiac dysfunction. Although COVID-19–related myocarditis is likely infrequent, COVID-19–related cardiovascular histopathology findings have been reported in up to 48% of patients, raising the concern for long-term myocardial injury. Studies to date report CMR abnormalities in 26% to 60% of hospitalized patients who have recovered from COVID-19, including functional impairment, myocardial tissue abnormalities, late gadolinium enhancement, or pericardial abnormalities. In athletes post–COVID-19, CMR has detected myocarditis-like abnormalities. In children, multisystem inflammatory syndrome may occur 2 to 6 weeks after infection; associated myocarditis and coronary artery aneurysms are evaluable by CMR. At this time, our understanding of COVID-19–related cardiovascular involvement is incomplete, and multiple studies are planned to evaluate patients with COVID-19 using CMR. In this review, we summarize existing studies of CMR for patients with COVID-19 and present ongoing research. We also provide recommendations for clinical use of CMR for patients with acute symptoms or who are recovering from COVID-19.
登录
查看更多内容
影响因子：
24
作者：
Daniels CJ;Rajpal S;Greenshields JT;Rosenthal GL;Chung EH;Terrin M;Jeudy J;Mattson SE;Law IH;Borchers J;Kovacs R;Kovan J;Rifat SF;Albrecht J;Bento AI;Albers L;Bernhardt D;Day C;Hecht S;Hipskind A;Mjaanes J;Olson D;Rooks YL;Somers EC;Tong MS;Wisinski J;Womack J;Esopenko C;Kratochvil CJ;Rink LD;Big Ten COVID-19 Cardiac Registry Investigators
通讯作者：
Big Ten COVID-19 Cardiac Registry Investigators
影响因子：
120.7
作者：
Feldstein, Leora R.;Tenforde, Mark W.;Randolph, Adrienne G.
通讯作者：
Randolph, Adrienne G.
影响因子：
2.3
作者：
Caro-Domínguez P;Navallas M;Riaza-Martin L;Ghadimi Mahani M;Ugas Charcape CF;Valverde I;D'Arco F;Toso S;Shelmerdine SC;van Schuppen J;Secinaro A;Gräfe D;Camacho M;Neth O;Goo HW;Kellenberger CJ
通讯作者：
Kellenberger CJ
DOI：
10.1016/j.jcmg.2020.10.023
发表时间：
2021-03
期刊：
JACC. Cardiovascular imaging
影响因子：
--
作者：
Brito D;Meester S;Yanamala N;Patel HB;Balcik BJ;Casaclang-Verzosa G;Seetharam K;Riveros D;Beto RJ 2nd;Balla S;Monseau AJ;Sengupta PP
通讯作者：
Sengupta PP
影响因子：
24
作者：
Giustino G;Croft LB;Stefanini GG;Bragato R;Silbiger JJ;Vicenzi M;Danilov T;Kukar N;Shaban N;Kini A;Camaj A;Bienstock SW;Rashed ER;Rahman K;Oates CP;Buckley S;Elbaum LS;Arkonac D;Fiter R;Singh R;Li E;Razuk V;Robinson SE;Miller M;Bier B;Donghi V;Pisaniello M;Mantovani R;Pinto G;Rota I;Baggio S;Chiarito M;Fazzari F;Cusmano I;Curzi M;Ro R;Malick W;Kamran M;Kohli-Seth R;Bassily-Marcus AM;Neibart E;Serrao G;Perk G;Mancini D;Reddy VY;Pinney SP;Dangas G;Blasi F;Sharma SK;Mehran R;Condorelli G;Stone GW;Fuster V;Lerakis S;Goldman ME
通讯作者：
Goldman ME